Holen Sie sich die Stockscreener-App
449.69
0.59%
-2.66
Handel nachbörslich:
450.25
0.56
+0.12%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$452.35
Offen:
$459.71
24-Stunden-Volumen:
2.46M
Relative Volume:
1.15
Marktkapitalisierung:
$161.20B
Einnahmen:
$9.15B
Nettoeinkommen (Verlust:
$2.63B
KGV:
62.75
EPS:
7.1661
Netto-Cashflow:
$1.99B
1W Leistung:
+2.38%
1M Leistung:
-3.68%
6M Leistung:
-0.42%
1J Leistung:
-6.69%
1-Tages-Spanne:
$449.08
$460.30
1-Wochen-Bereich:
$430.34
$460.30
52-Wochen-Spanne:
$425.00
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
449.69 | 162.16B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
191.99 | 55.49B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
281.38 | 40.66B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
76.82 | 38.26B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
268.07 | 19.60B | 2.96B | 487.70M | 344.00M | 6.68 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-23 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Surgical Robotic System Market Poised for Significant Growth - openPR.com
Will Intuitive Surgical Inc. (IUI1) stock keep high P E multiplesJuly 2025 WrapUp & Real-Time Market Sentiment Reports - newser.com
Is Intuitive Surgical Inc. stock affected by interest rate hikesWeekly Profit Analysis & Weekly Market Pulse Alerts - newser.com
How Intuitive Surgical Inc. stock performs in high volatility marketsQuarterly Profit Report & Free Weekly Watchlist of Top Performers - newser.com
The top surgical robotics stories of 2025 so far - MassDevice
How higher bond yields impact Intuitive Surgical Inc. (IUI1) stockWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
Evaluating Intuitive Surgical Inc. with trendline analysis2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
Is Intuitive Surgical Inc. showing signs of accumulationWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
Is Intuitive Surgical Inc. still worth holding after the dipTrade Analysis Summary & Stepwise Trade Signal Guides - newser.com
Should You Buy Shares of Intuitive Surgical In October? - The Motley Fool
Visual trend scoring systems applied to Intuitive Surgical Inc.Quarterly Profit Review & Community Consensus Trade Signals - newser.com
Intuitive Surgical Inc Stock Analysis and ForecastHead and Shoulders Patterns & Free Professional Investment Consultations - earlytimes.in
How AI-Powered da Vinci 5 Expansion and Global Growth Could Influence Intuitive Surgical (ISRG) Investors - simplywall.st
How to build a custom watchlist for Intuitive Surgical Inc.July 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Multi asset correlation models including Intuitive Surgical Inc.Quarterly Profit Report & Expert Approved Momentum Ideas - newser.com
Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
PATENT—Fed. Cir.: $10 million jury damages award cut to $1 despite proven infringement of surgical stapler patent - VitalLaw.com
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing - sharewise.com
Reasons to Retain Intuitive Surgical Stock in Your Portfolio Now - MSN
How Does Intuitive Surgical Stack Up After Recent FDA Robot Surgery Guidance in 2025? - simplywall.st
Intuitive Surgical (ISRG): Assessing Valuation as New Telesurgery Advances and Global Regulatory Wins Drive Growth - simplywall.st
Morgan Stanley Remains Bullish on Intuitive Surgical (ISRG) - Insider Monkey
Intuitive Surgical Inc. (ISRG) Upgrades da Vinci 5 Making it 10,000 Times Powerful for Surgeries - MSN
Will Intuitive Surgical Inc. (IUI1) stock outperform benchmarksJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
How Intuitive Surgical Inc. (IUI1) stock trades in high volatilityMarket Volume Summary & AI Enhanced Trading Alerts - newser.com
Fed. Circ. Affirms Cutting $10M Med Device IP Verdict To $1 - Law360
Global General Surgery Devices Market to Register Sustainable Growth at a CAGR of ~6% by 2032 | DelveInsight - GlobeNewswire Inc.
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet - sharewise.com
This Medical Device Giant Could Be Your Best Inflation Hedge - AOL.com
Congressional Trading Report: Sen. Markwayne Mullin Bought Over $81K In Intuitive Surgical Stock - Benzinga
Intuitive Surgical Stock (ISRG) Opinions on Recent Performance and Innovation - Quiver Quantitative
Meet the 3%-Yielding Dividend Stock That Could Soar in 2026 - AOL.com
Intuitive Surgical’s (ISRG) “Buy” Rating Reaffirmed at BTIG Research - Defense World
Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $567.00 at The Goldman Sachs Group - Defense World
Best Healthcare Stocks To Keep An Eye On – September 30th - Defense World
What You Need To Know Ahead of Intuitive Surgical's Earnings Release - MSN
Intuitive Surgical, Inc. (ISRG) Unveils AI-Powered da Vinci 5 Upgrades - MSN
SS Innovations International, Inc. (SSII)’s SSi Mantra System Sees 130% Installation Growth, Pioneers Cardiac Telesurgery - MSN
ISRG Expands SP Indications: A Game Changer in Colorectal Surgery? - The Globe and Mail
Intuitive Surgical Inc (ISRG) Stock Price, Trades & News - GuruFocus
Is Intuitive Surgical the Hidden Winner in Healthcare’s Weakness? - MarketBeat
The top Intuitive Surgical stories of 2025 so far - MassDevice
BTIG Reiterates Intuitive Surgical (ISRG) Buy Recommendation - Nasdaq
Goldman Sachs Adjusts Price Target on Intuitive Surgical to $567 From $621, Maintains Buy Rating - MarketScreener
3 Reasons to Buy Intuitive Surgical Stock Near Its 52-Week Low - Mitrade
Exploring Analyst Estimates for Intuitive Surgical (ISRG) Q4 Earnings, Beyond Revenue and EPS - MSN
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.84%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):